These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3977650)

  • 1. The dexamethasone suppression test. An indicator of depression in stroke but not a predictor of rehabilitation outcome.
    Reding M; Orto L; Willensky P; Fortuna I; Day N; Steiner SF; Gehr L; McDowell F
    Arch Neurol; 1985 Mar; 42(3):209-12. PubMed ID: 3977650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone suppression test and onset of poststroke depression in patients with ischemic infarction.
    Harney JH; Fulton C; Ross ED; Rush AJ
    J Clin Psychiatry; 1993 Sep; 54(9):343-8. PubMed ID: 8407853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dexamethasone suppression test for diagnosing depression in stroke patients.
    Harvey SA; Black KJ
    Ann Clin Psychiatry; 1996 Mar; 8(1):35-9. PubMed ID: 8743648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone suppression test and depression in a rehabilitation setting.
    Bauer M; Gans JS; Harley JP; Cobb W
    Arch Phys Med Rehabil; 1983 Sep; 64(9):421-2. PubMed ID: 6615180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression and the dexamethasone suppression test (DST) in patients with non-specific somatic complaints. Atypical depression and DST.
    Syvälahti E; Hyyppä MT; Salminen JK
    Ann Clin Res; 1985; 17(4):148-51. PubMed ID: 4073803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mood, vegetative disturbance, and dexamethasone suppression test after stroke.
    Finklestein S; Benowitz LI; Baldessarini RJ; Arana GW; Levine D; Woo E; Bear D; Moya K; Stoll AL
    Ann Neurol; 1982 Nov; 12(5):463-8. PubMed ID: 6960804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the dexamethasone suppression test with depressed and demented elderly.
    Gierl B; Groves L; Lazarus LW
    J Am Geriatr Soc; 1987 Feb; 35(2):115-20. PubMed ID: 3805553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of the dexamethasone test in the differential diagnosis of depressive states].
    Nuller IuL; Ostroumova MN; Gordon OI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(4):547-51. PubMed ID: 3716705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry.
    Am J Psychiatry; 1987 Oct; 144(10):1253-62. PubMed ID: 3310667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dexamethasone suppression test and mood following stroke.
    Lipsey JR; Robinson RG; Pearlson GD; Rao K; Price TR
    Am J Psychiatry; 1985 Mar; 142(3):318-23. PubMed ID: 3970268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone suppression test and depressive symptoms in bereaved children: a preliminary report.
    Weller EB; Weller RA; Fristad MA; Bowes JM
    J Neuropsychiatry Clin Neurosci; 1990; 2(4):418-21. PubMed ID: 2136395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalization of dexamethasone suppression test: a laboratory index of recovery from endogenous depression.
    Greden JF; Albala AA; Haskett RF; James NM; Goodman L; Steiner M; Carroll BJ
    Biol Psychiatry; 1980 Jun; 15(3):449-58. PubMed ID: 7378518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of the dexamethasone suppression test in the diagnosis of poststroke depression.
    Grober SE; Gordon WA; Sliwinski MJ; Hibbard MR; Aletta EG; Paddison PL
    Arch Phys Med Rehabil; 1991 Dec; 72(13):1076-9. PubMed ID: 1741660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different linkage of depression to hypercortisolism early versus late after stroke. A 3-year longitudinal study.
    Aström M; Olsson T; Asplund K
    Stroke; 1993 Jan; 24(1):52-7. PubMed ID: 8418550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosing depression after stroke.
    Black KJ
    South Med J; 1995 Jul; 88(7):699-708. PubMed ID: 7597471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.
    Bschor T; Baethge C; Adli M; Eichmann U; Ising M; Uhr M; Müller-Oerlinghausen B; Bauer M
    Depress Anxiety; 2003; 17(1):43-8. PubMed ID: 12577277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4 p.m. baseline cortisol level as a predictor of DST results in depression.
    Weiler MA; Jobe TH; Nasr SJ; Pandey G; Altman EG
    J Clin Psychiatry; 1986 Feb; 47(2):60-2. PubMed ID: 3944064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to dexamethasone and subtype of depression.
    Brown WA; Shuey I
    Arch Gen Psychiatry; 1980 Jul; 37(7):747-51. PubMed ID: 7190379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dexamethasone suppression test in depressed patients: clinical and biochemical aspects.
    Holsboer F
    J Steroid Biochem; 1983 Jul; 19(1A):251-7. PubMed ID: 6887861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in serial dexamethasone suppression tests among unipolar depressive receiving electroconvulsive treatment.
    Albala AA; Greden JF; Tarika J; Carroll BJ
    Biol Psychiatry; 1981 Jun; 16(6):551-60. PubMed ID: 7260217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.